Triptans in the treatment of basilar migraine and migraine with prolonged aura.

Objective.—To report on the use of triptans in migraine with prominent neurologic symptoms. Background.—As stated in their package inserts, the triptans are contraindicated in patients with basilar or familial hemiplegic migraine, and physicians are reluctant to prescribe these drugs to other patients with prominent or prolonged aura. Methods.—We evaluated 13 patients with basilar migraine, familial hemiplegic migraine, or migraine with prominent or prolonged aura who had received triptans. Results.—Excellent; no adverse events. Conclusion.—The contraindication of triptans in basilar migraine should be reconsidered. Similarly, prominent or prolonged aura may not represent a reasonable contraindication to triptan therapy.